The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Outcome stagnation of liver transplantation for primary sclerosing cholangitis in the Model for End-Stage Liver Disease era
Open accessAbstract
PURPOSE: Survival after liver transplantation (LTX) has decreased in Germany since the implementation of Model for end-stage liver disease (MELD)-based liver allocation. Primary sclerosing cholangitis (PSC) is known for its otherwise excellent outcome after LTX. The influence of MELD-based liver allocation and subsequent allocation policy alterations on the outcome of LTX for PSC is analyzed. METHODS: This is a retrospective observational study including 126 consecutive patients treated with LTX for PSC between January 1, 1999 and August 31, 2012. The PSC cohort was further compared to all other indications for LTX in the study period (n=1420) with a mean follow-up of 7.9 years (SD 3.2). Multivariate risk-adjusted analyses were performed. Alterations of allocation policy have been taken into account systematically. RESULTS: Transplant recipients suffering from PSC are significantly younger (p<0.001), can be discharged earlier (p=0.018), and have lower 3-month mortality than patients with other indications (p=0.044). The observed time on the waiting list is significantly longer for patients with PSC (p<0.001), and there is a trend toward lower match MELD points in the PSC cohort (p=0.052). No improvement in means of short-term mortality could be shown in relation to alterations of allocation policy within the MELD era (p=0.375). Survival rates of the pre-MELD era did not differ significantly from those of the MELD era (p=0.097) in multivariate risk-adjusted analysis. Patients in the MELD era suffered pre-transplant significantly more frequently from dominant bile duct stenosis (p=0.071, p=0.059, p=0.048, respectively; chi2). CONCLUSIONS: Progress is stagnating in LTX for PSC. Current liver allocation for PSC patients should be reconsidered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some analyses suggest that people with PSC have a better outcome following liver transplantation than patients with similar MELD scores transplanted for other indications, 397 and that bacterial cholangitis does not increase waitlist mortality, adding to the difficulty in applying standardised listing procedures to the PSC population both in MELD-based and consensus-based transplant programmes.389”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [389]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dindo, D., Demartines, N., & Clavien, P.-A. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000133083.54934.ae · Cited by 31,378 · cited 1×
“[13].”
Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk Index
Feng, S., Goodrich, N. P., Bragg-Gresham, J. L., Dykstra, D. M., Punch, J. D., DebRoy, M. A., Greenstein, S. M., & Merion, R. M. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01242.x · Cited by 1,958 · cited 1×
“It is undisputed that the short-term and long-term prognoses after LTX are largely dependent on the nature of the underlying liver disease, the overall morbidity and condition of the recipient, and donor liver quality, which is notoriously difficult to define [23–26].”
BackgroundBambha, K., Kim, W. R., Talwalkar, J., Torgerson, H., Benson, J. T., Therneau, T. M., Loftus, E. V., Yawn, B. P., Dickson, E. R., & Melton, L. J. (2003) · Gastroenterology · doi:10.1016/j.gastro.2003.07.011 · Cited by 450 · cited 1×
“increased risk of developing cholangiocarcinoma (CC) as well as the impact of concomitant inflammatory bowel disease (IBD) which appears to be present in 70–80 % of all PSC patients and an additionally increased risk of colorectal cancer [1, 4, 5].”
BackgroundRoberts, M. S., Angus, D. C., Bryce, C. L., Valenta, Z., & Weissfeld, L. (2004) · Liver Transplantation · doi:10.1002/lt.20137 · Cited by 383
Cameron, A. M., Ghobrial, R. M., Yersiz, H., Farmer, D. G., Lipshutz, G. S., Gordon, S. A., Zimmerman, M., Hong, J., Collins, T. E., Gornbein, J., et al. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000219669.84192.b3 · Cited by 257 · cited 1×
“However, it has been shown that current donor organ quality scores (DRI, ECD score, D-MELD score, ET-DRI) did not influence outcome after LTX in our center in the MELD era [24, 35].”
BackgroundFreeman, R. B., Gish, R. G., Harper, A., Davis, G. L., Vierling, J., Lieblein, L., Klintmalm, G., Blazek, J., Hunter, R., & Punch, J. (2006) · Liver Transplantation · doi:10.1002/lt.20979 · Cited by 179
Recurrence and rejection in liver transplantation for primary sclerosing cholangitis
Fosby, B. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i1.1 · Cited by 175 · cited 3×
“One or more episodes of rejection early after LTX are suspected to be associated with PSC recurrence [32].”
BackgroundResultCurrent views on rejection pathology in liver transplantation
Neil, D., & Hübscher, S. G. (2010) · Transplant International · doi:10.1111/j.1432-2277.2010.01143.x · Cited by 154 · cited 1×
“The high frequency of rejections is in line with data from the literature reporting of 20–40 % of patients who will suffer from at least one episode of rejection [32, 33].”
ResultPrimary sclerosing cholangitis: Liver transplantation or biliary surgery
Farges, O., Malassagne, B., Sebagh, M., & Bismuth, H. (1995) · Surgery · doi:10.1016/s0039-6060(05)80078-9 · Cited by 147 · cited 1×
“Hepatobiliary surgery prior to LTX is known to affect the outcome negatively even after exclusion of patients with malignancy [3, 29, 30].”
BackgroundWeismüller, T. J., Fikatas, P., Schmidt, J., Barreiros, A. P., Otto, G., Beckebaum, S., Paul, A., Scherer, M. N., Schmidt, H., Schlitt, H. J., et al. (2010) · Transplant International · doi:10.1111/j.1432-2277.2010.01161.x · Cited by 146 · cited 14×
“Following MELD introduction, the regular allocation threshold has increased in Germany from a MELD of initially 25 to now 34 points.”
BackgroundMethodResultInfluentialSelf-citation
Research works printed but not linked: 3
- German Medical Association (2008) Richtlinien zur Organtransplantation gem. § 16 TPG. Dtsch Arztebl 105:A1461–A1464
- German Medical Association (2012) Richtlinien zur Organtransplantation gem. § 16 Abs. 1 S. 1 Nrn. 2 u. 5 TPG. Dtsch Arztebl 108:A662–A674
- Eurotransplant Manual version 4.3; September 26, 2013; Chapter 5: 10–19
Cited by
Primary sclerosing cholangitis – a comprehensive review
Karlsen, T. H., Folseraas, T., Thorburn, D., & Vesterhus, M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.07.022 · Cited by 868
EASL Clinical Practice Guidelines on sclerosing cholangitis
Chazouilleres, O., Beuers, U., Bergquist, A., Karlsen, T. H., Levy, C., Samyn, M., Schramm, C., & Trauner, M. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.05.011 · Cited by 419
Ponsioen, C. Y., Assis, D. N., Boberg, K. M., Bowlus, C. L., Deneau, M., Thorburn, D., Aabakken, L., Färkkilä, M., Petersen, B., Rupp, C., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.07.046 · Cited by 95
Carbone, M., Penna, A. D., Mazzarelli, C., Martin, E. D., Villard, C., Bergquist, A. M., Line, P., Neuberger, J., Al-Shakhshir, S., Trivedi, P. J., et al. (2023) · Transplant International · doi:10.3389/ti.2023.11729 · Cited by 61
“A German study analyzed the temporal effect and found no difference on the WL mortality in the pre-MELD versus the post-MELD era [12].”
BackgroundVoigtländer, T., Jaeckel, E., Lehner, F., Manns, M. P., & Lankisch, T. O. (2015) · Liver Transplantation · doi:10.1002/lt.24192 · Cited by 27
“This may lead to lower MELD scores in the initial phase of ICU treatment and higher scores in the late phase of multiple organ dysfunction, which may hamper LT.1,14 Comparable to patients with SSC-CIP, patients with PSC show biliary alterations that may lead to LT.15 PSC is an excellent indication for LT as the long-t…”
BackgroundInfluentialSelf-citation
Metadata
- Authors
- Klose, J., Klose, M. A., Metz, C., Lehner, F., Manns, M. P., Klempnauer, J., Hoppe, N., Schrem, H., & Kaltenborn, A.
- Affiliations
- Heidelberg University (DE)
- Medizinische Hochschule Hannover (DE)
- Leibniz University Hannover (DE)
- Corresponding author
- Klose, Johannes
- ORCID
- Venue
- Langenbeck's Archives of Surgery
- Published
- 2014-06-04
- Volume
- 399
- Issue
- 8
- Pages
- 1021-1029
- ISSN
- 0023-8236 (ISSN-L)
- 1435-2443
- 1435-2451
- PMC
- PMC4232743
- OpenAlex
- W2102192330
- Cited by
- 21
- References
- 33
- Citations by year
- 2025: 1 · 2024: 3 · 2023: 2 · 2022: 1 · 2021: 3 · 2019: 1 · 2018: 1 · 2017: 3 · 2016: 1 · 2015: 2 · 2014: 3
- FWCI
- 2.97
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Langenbeck s Archives of Surgery (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Institutional Repository of Leibniz Universität Hannover (Leibniz Universität Hannover) (submittedVersion, cc-by-nc-nd)
- Institutional Repository of Leibniz Universität Hannover (Leibniz Universität Hannover) (submittedVersion, cc-by)
- Leibniz Universität Hannover (cc-by)
- Topics
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Keywords
- liver transplantation, primary sclerosing cholangitis, MELD score, liver allocation policy, graft survival, waitlist time, bile duct stenosis, post-transplant mortality
- MeSH terms
- Adolescent, Adult, Aged, Child, Child, Preschool, Female, Germany, Health Policy, Humans, Length of Stay, Male, Middle Aged, Postoperative Complications, Retrospective Studies, Waiting Lists, Cholangitis, Sclerosing, Survival Rate, Liver Transplantation, Treatment Outcome, Risk Assessment, End Stage Liver Disease, Operative Time
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Outcome stagnation of liver transplantation for primary sclerosing cholangitis in the Model for End-Stage Liver Disease era. https://app.cochat.ai/papers/10.1007/s00423-014-1214-6
- The paper
- Klose, J., Klose, M. A., Metz, C., Lehner, F., Manns, M. P., Klempnauer, J., Hoppe, N., Schrem, H., & Kaltenborn, A. (2014). Outcome stagnation of liver transplantation for primary sclerosing cholangitis in the Model for End-Stage Liver Disease era. Langenbeck's Archives of Surgery. https://doi.org/10.1007/s00423-014-1214-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
